MCM6 and gastric cancer: Recently, in gastric cancer, Wang et al. identified purpureaside C as a novel MCM6 inhibitor, and showed that, in vitro, this treatment suppressed gastric carcinoma cell growth and synergized with 5-fluorouracil to induce cell death [33].